QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 investment-advisor-says-throwing-random-darts-at-tickers-would-beat-arkk-as-cathie-woods-flagship-fund-lags-far-behind-soaring-market-how-do-they-do-it

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500&...

 btig-downgrades-ginkgo-bioworks-holdings-to-sell

BTIG analyst Mark Massaro downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.

 morgan-stanley-maintains-equal-weight-on-ginkgo-bioworks-holdings-lowers-price-target-to-1

Morgan Stanley analyst Tejas Savant maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Equal-Weight and lowers the price t...

 ginkgo-bioworks-receives-notice-of-continued-listing-standard-notice-from-nyse

Ginkgo's Class A Common Stock continues to trade on the NYSEBOSTON, May 13, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, ...

 william-blair-downgrades-ginkgo-bioworks-holdings-to-underperform

William Blair analyst Matt Larew downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Market Perform to Underperform.

 ginkgo-bioworks-stock-falls-on-disappointing-q1-sales-this-trend-needs-to-change

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47...

 ginkgo-bioworks-holdings-q1-2024-gaap-eps-008-beats-009-estimate-sales-38000m-miss-46044m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of...

 ginkgo-bioworks-holdings-q1-sales-38000m-miss-46044m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly sales of $38.000 million which missed the analyst consensus estimate of ...

 modalis-therapeutics-partners-with-ginkgo-bioworks-enhancing-cell-and-gene-therapy-with-crispr-gndm-technology

Modalis Joins Ginkgo's Technology Network Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announce...

 whats-going-on-with-ginkgo-bioworks-stock

Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agree...

 ginkgo-bioworks-reports-acquisition-of-agbiomes-platform-assets

The deal includes over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant funct...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION